A detailed history of Artia Global Partners LP transactions in Insmed Inc stock. As of the latest transaction made, Artia Global Partners LP holds 52,939 shares of INSM stock, worth $3.69 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
52,939
Previous 53,436 0.93%
Holding current value
$3.69 Million
Previous $3.58 Billion 7.94%
% of portfolio
1.05%
Previous 0.69%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $30,814 - $39,267
-497 Reduced 0.93%
52,939 $3.86 Billion
Q2 2024

Aug 14, 2024

SELL
$22.0 - $69.71 $1.43 Million - $4.52 Million
-64,800 Reduced 54.81%
53,436 $3.58 Billion
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $1.11 Million - $1.3 Million
43,300 Added 57.78%
118,236 $3.21 Billion
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $1.76 Million - $2.38 Million
74,936 New
74,936 $2.32 Billion

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.43B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.